PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown...
PDGF was found to be a major mitogenic factor present in serum but absent in plasma. It is secreted by the alpha granules of the platelets, activated during blood clotting to form serum. Studies have shown that PDGF did not correspond to one but to three molecules, each being a dimeric combination of two distinct but structurally related peptide chains called A and B. Dimeric isoforms PDGF-AA, AB, and BB are expressed differentially in various cell types and their effects are mediated by two distinct receptors, alpha and beta. There are differences in the binding of these isoforms to each receptor. In general, PDGF isoforms are potent mitogens for connective tissue cells, including dermal fibroblasts, glial cells, arterial smooth muscle cells, and certain epithelial and endothelial cells. In addition to its mitogen activity, PDGF is chemotactic for fibroblasts, smooth muscle cells and mononuclear cells. Other reported activities include stimulation of granule release by neutrophils and monocytes, facilitation of steroid synthesis by Leydig cells, stimulation of neutrophil phagocytosis, inhibition of natural killer cell activity (NK), modulation of thrombospondin expression and secretion, stimulation of collagenase activity and secretion and transient induction of T-cell secretion of IL-2, accompanied by decreasing regulation of the production of IL-4 and d-IFN-gamma, temporary effects that may allow the clone expansion of Auxiliary B and T lymphocytes activated by antigen prior to differentiation
Sensitivity
Sensitivity of the dosage: 40 pg/ml.
Measurement range
Dosing range: 41.15 to 30.000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17787993 |
| Specifications |
| Accession number | P04085 |
| Dose range | 41.15 to 30 000 pg/ml |
| Sensitivity of the dosage | 40 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 5154 |
| Gene symbol(s) | Pdgfa |
| Coefficient of inter-dose variation | < 12% |
| Coefficient of intra-dose variation | < 10% |
| Contents of kits | 96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 10 x 96 tests |
| Regulatory status | RUO |
| Target | PDGF-AA |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 5 μl-Serum, 5 μl-Surnatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHPDGFAX10 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.